Army Dengue Vaccine Trial Supported by State University of New York
The United States Army Medical Research Acquisition Activity (USAMRAA) is awarding a new contract in support of an experimental dengue ...
The United States Army Medical Research Acquisition Activity (USAMRAA) is awarding a new contract in support of an experimental dengue ...
The Food and Drug Administration (FDA) this week approved the use of Novartis’ Flucelvax vaccine in adults, becoming the first ...
The United States Patent and Trademark Office has granted the co-founders of Adjuvance Technologies, Inc., a patent for a pioneering ...
An extended proposal deadline has been issued by the National Institutes of Health (NIH) and the Centers for Disease Control and ...
The Naval Medical Research Center (NMRC) Malaria Program, in pursuit of a long-term goal of developing malaria vaccines to protect ...
Apichai Tuanyok dedicated several years to working on a bacterial pathogen in Canada, but his breakthrough occurred in Flagstaff with an ...
The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Request for Information (RFI) seeking input from product ...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Pfenex, Inc., a contract to develop an alternative dry ...
Emergent Biosolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) ...
The National Institutes of Health (NIH) last month awarded three Phase I Small Business Innovation Research (SBIR) grants to Protein ...
iBio, Inc. this week announced issuance of a U.S. patent covering compositions of matter and methods of producing and formulating anthrax ...
The U.S. Department of Health and Human Services (HHS) has taken historic steps to support the nation’s pandemic preparedness efforts ...
Soligenix last week announced the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of ...
The National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation is renewing a Broad Agency ...
The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses ...
In a recent milestone development under the Defense Advanced Research Project Agency (DARPA) “Blue Angel” program, researchers at Medicago Inc. ...
Researchers have developed a new silk-based stabilizer that shows benefit for keeping vaccines and antibiotics stable up to temperatures of ...
Scientists at the Plum Island Animal Disease Center (PIADC) have developed a molecular vaccine against foot and mouth disease virus ...
The Infectious Disease Research Institute (IDRI) of Seattle, WA will be teaming up with biopharmaceutical company Soligenix to develop biodefense ...
Merck & Co., Inc., West Point, Pa., was awarded a firm-fixed-price contract with a maximum of $11,555,970 for flu vaccines ...